Lowers FY25 revenue view to C$7.6B-C$7.8B from C$7.8B-C$8B. Raises FY25 normalized EBITDA view to C$1.02B-C$1.07B from C$890M-C$940M. Lowers FY25 capital expenditures view to C$430M from C$475M.

Backs FY25 organic net sales view flat to up 1%. Lowers FY25 adjusted operating profit view to down 2%-4% from flat to down 2%. The company said, “Amid an uncertain macroeconomic backdrop for ...

Consensus for FY25 EPS is $14.98. Increased FY25 EPS guidance reflects the expected contribution from the closing of the RCA acquisition and also continued momentum in the U.S. Healthcare ...

Illustration: Dominic Xavier/Rediff.com The Indian IT services industry is expected to clock revenue growth in the mid-single digit for the financial year 2024-2025 (FY25), according to a report ...

FY25 Sales expected to decline ~5%; adjusted EPS forecast at the lower end of $4.90-$5.20 range. Apogee Enterprises, Inc. APOG shares are trading lower after the company reported third-quarter ...